标题/作者	年份
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies A Achiron, M Mandel, S Dreyer-Alster, G Harari, D Magalashvili, P Sonis, ... Therapeutic advances in neurological disorders 14, 17562864211012835	2021
Anxiety and depression in health workers and general population during COVID‐19 in Iran: a cross‐sectional study L Hassannia, F Taghizadeh, M Moosazadeh, M Zarghami, H Taghizadeh, ... Neuropsychopharmacology reports 41 (1), 40-49	2021
Auto-immune hepatitis following COVID vaccination M Rela, D Jothimani, M Vij, A Rajakumar, A Rammohan Journal of Autoimmunity 123, 102688	2021
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study A Achiron, M Mandel, S Dreyer-Alster, G Harari, M Dolev, S Menascu, ... Journal of Neuroimmunology 361, 577746	2021
A global picture: therapeutic perspectives for COVID-19 VP Chavda, C Kapadia, S Soni, R Prajapati, SC Chauhan, MM Yallapu, ... Immunotherapy 14 (5), 351-371	2022
Humoral immune response after the third SARS-CoV-2 mRNA vaccination in CD20 depleted people with multiple sclerosis L Achtnichts, B Jakopp, M Oberle, K Nedeltchev, CA Fux, J Sellner, ... Vaccines 9 (12), 1470	2021
Post-COVID-19 pulmonary fibrosis A Mohammadi, I Balan, S Yadav, WF Matos, A Kharawala, M Gaddam, ... Cureus 14 (3)	2022
Effect of different disease-modifying therapies on humoral response to BNT162b2 vaccine in Sardinian multiple sclerosis patients M Pitzalis, ML Idda, V Lodde, A Loizedda, M Lobina, M Zoledziewska, ... Frontiers in immunology 12, 781843	2021
Effect of Coronary Artery Disease on COVID-19—Prognosis and Risk Assessment: A Systematic Review and Meta-Analysis L Szarpak, M Mierzejewska, J Jurek, A Kochanowska, A Gasecka, ... Biology 11 (2), 221	2022
COVID-19 in joint ageing and osteoarthritis: current status and perspectives M Lauwers, M Au, S Yuan, C Wen International Journal of Molecular Sciences 23 (2), 720	2022
Epidemiology of systemic mycoses in the COVID-19 pandemic MG Frias-De-Leon, R Pinto-Almazán, R Hernández-Castro, ... Journal of Fungi 7 (7), 556	2021
Acceptance of COVID-19 vaccine among persons experiencing homelessness in the City of Rome, Italy C Iacoella, M Ralli, A Maggiolini, A Arcangeli, L Ercoli European review for medical and pharmacological sciences 25 (7), 3132-3135	2021
Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS MP Szabo, M Iba, A Nath, E Masliah, C Kim Experimental & Molecular Medicine 54 (4), 447-454	2022
Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus Y Hartini, B Saputra, B Wahono, Z Auw, F Indayani, L Adelya, G Namba, ... Results in chemistry 3, 100087	2021
Coalescence of co-infection and antimicrobial resistance with SARS-CoV-2 infection: The blues of post-COVID-19 world P Mazumder, A Kalamdhad, GGT Chaminda, M Kumar Case Studies in Chemical and Environmental Engineering 3, 100093	2021
Role of functional food components in COVID-19 pandemic: A review H Hamid, A Thakur, NS Thakur Ann. Phytomed. Int. J 10 (1), 5240-5250	2021
Biomedical text link prediction for drug discovery: a case study with COVID-19 K McCoy, S Gudapati, L He, E Horlander, D Kartchner, S Kulkarni, ... Pharmaceutics 13 (6), 794	2021
Pharmacological adherence behavior changes during COVID-19 outbreak in a Portugal patient cohort L Midão, M Almada, J Carrilho, R Sampaio, E Costa International Journal of Environmental Research and Public Health 19 (3), 1135	2022
The role of indoor plants in air purification and human health in the context of COVID-19 pandemic: a proposal for a novel line of inquiry R El-Tanbouly, Z Hassan, S El-Messeiry Frontiers in Molecular Biosciences 8, 709395	2021
An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19) A Alagheband Bahrami, A Azargoonjahromi, S Sadraei, A Aarabi, ... Cellular & molecular biology letters 27 (1), 38	2022

1 - 20

计算机程序会自动估算并确定日期和引用次数。